SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-045742
Filing Date
2023-12-21
Accepted
2023-12-21 17:00:28
Documents
12
Period of Report
2023-12-15
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43358
  Complete submission text file 0001493152-23-045742.txt   215355

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cocp-20231215.xsd EX-101.SCH 3036
3 XBRL LABEL FILE cocp-20231215_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE cocp-20231215_pre.xml EX-101.PRE 22373
6 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3194
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38418 | Film No.: 231506026
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)